Skip to content

Caerus Pharma

Active Risk: not assessed
Limited partnershipfounded 2026active for less than a yearPastuurdijk 15, 8301 Knokke-Heist, BelgiumKBO/BCE: BE 1035.787.378
Summary

Caerus Pharma is less than twelve months old; there is no public track record yet to compute a bankruptcy probability from. The company has been active since 2026 and the Belgian Official Gazette contains no insolvency or warning signals. No annual accounts have been filed with the National Bank.

Risk analysisFollow ReportCompare
Caerus PharmaActive
Risk analysis ReportCompare

Articles of association

What the company does

DurationHow long the company exists; usually unlimited, so until it is dissolved.
Unlimited
Name clauseThe name the company operates under according to its articles.
Caerus Pharma
Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
“Geen, Pastuurdijk 15,8301 Knokke-Heist” (deed in Dutch)

deed of 24-03-2026

Who represents it, and how

Board ruleHow the board is made up, meets and takes decisions.
“Bepaalde of onbepaalde duur, één of meerdere zaakvoerders” (deed in Dutch)

deed of 24-03-2026

Meetings and financial year

Financial yearThe twelve-month period the company draws up its annual accounts for.
From 1 January to 31 December
Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
In June

deed of 24-03-2026

Other provisionsOther rules from the articles that fall under none of the themes above.

Other provision: “6°, vennootschapsvermogen” (deed in Dutch)
Other provision: “Aanwending resultaat,winstverdeling en reservevorming, gewone meerderheid” (deed in Dutch)
Other provision: “Overlijden,vereffening,faillissement,kennelijk onvermogen,onbekwaamheid of verhindering zaakvoerder, 1 maand” (deed in Dutch)

deed of 24-03-2026

We would like to set cookies. That happens only with your consent. What we measure